Search details
1.
Anti-myostatin antibody increases muscle mass and strength and improves insulin sensitivity in old mice.
Proc Natl Acad Sci U S A
; 113(8): 2212-7, 2016 Feb 23.
Article
in English
| MEDLINE | ID: mdl-26858428
2.
Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and response.
Breast Cancer Res
; 17: 73, 2015 May 29.
Article
in English
| MEDLINE | ID: mdl-26021444
3.
Expression profiling of circulating tumor cells in metastatic breast cancer.
Breast Cancer Res Treat
; 149(1): 121-31, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25432738
4.
Abiraterone and increased survival in metastatic prostate cancer.
N Engl J Med
; 364(21): 1995-2005, 2011 May 26.
Article
in English
| MEDLINE | ID: mdl-21612468
5.
Physical activity and prostate gene expression in men with low-risk prostate cancer.
Cancer Causes Control
; 25(4): 515-23, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-24504435
6.
Lymph Node-Targeted Vaccine Boosting of TCR T-cell Therapy Enhances Antitumor Function and Eradicates Solid Tumors.
Cancer Immunol Res
; 12(2): 214-231, 2024 02 02.
Article
in English
| MEDLINE | ID: mdl-38270373
7.
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial.
Nat Med
; 30(2): 531-542, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38195752
8.
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study.
Lancet Oncol
; 13(10): 983-92, 2012 Oct.
Article
in English
| MEDLINE | ID: mdl-22995653
9.
Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial.
Lancet Oncol
; 13(12): 1210-7, 2012 Dec.
Article
in English
| MEDLINE | ID: mdl-23142059
10.
Lymph node targeted multi-epitope subunit vaccine promotes effective immunity to EBV in HLA-expressing mice.
Nat Commun
; 14(1): 4371, 2023 08 08.
Article
in English
| MEDLINE | ID: mdl-37553346
11.
Amphiphile-CpG vaccination induces potent lymph node activation and COVID-19 immunity in mice and non-human primates.
NPJ Vaccines
; 7(1): 128, 2022 Oct 28.
Article
in English
| MEDLINE | ID: mdl-36307453
12.
Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention.
Proc Natl Acad Sci U S A
; 105(24): 8369-74, 2008 Jun 17.
Article
in English
| MEDLINE | ID: mdl-18559852
13.
A lymph node-targeted Amphiphile vaccine induces potent cellular and humoral immunity to SARS-CoV-2.
Sci Adv
; 7(6)2021 02.
Article
in English
| MEDLINE | ID: mdl-33547083
14.
Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy.
NMR Biomed
; 23(4): 391-8, 2010 May.
Article
in English
| MEDLINE | ID: mdl-20033906
15.
A comparison of RNA amplification techniques at sub-nanogram input concentration.
BMC Genomics
; 10: 326, 2009 Jul 20.
Article
in English
| MEDLINE | ID: mdl-19619282
16.
First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid Tumors.
Clin Cancer Res
; 25(18): 5458-5465, 2019 Sep 15.
Article
in English
| MEDLINE | ID: mdl-31068369
17.
Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer.
Urol Oncol
; 25(2): 134-40, 2007.
Article
in English
| MEDLINE | ID: mdl-17349528
18.
Molecular correlates of site-specific metastasis.
Semin Radiat Oncol
; 16(2): 102-10, 2006 Apr.
Article
in English
| MEDLINE | ID: mdl-16564445
19.
Peroxisome proliferator-activated receptor (PPAR)-beta/delta stimulates differentiation and lipid accumulation in keratinocytes.
J Invest Dermatol
; 122(4): 971-83, 2004 Apr.
Article
in English
| MEDLINE | ID: mdl-15102088
20.
Efficacy and safety of abiraterone acetate in an elderly patient subgroup (aged 75 and older) with metastatic castration-resistant prostate cancer after docetaxel-based chemotherapy.
Eur Urol
; 65(5): 875-83, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24099659